Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Oktober 2024

Biotek-snakken — Oktober 2024

Planlagt Fastgjort Låst Flyttet Biotek-snakken
76 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • exitnuE Offline
    exitnuE Offline
    exitnu
    wrote on sidst redigeret af
    #11

    Styrelseledamot i Genovis köper sina första aktier i bolaget - Steven Jordan har den 2 oktober köpt 5 010 aktier i bioteknikbolaget Genovis där han är styrelseledamot. Aktierna köptes till kursen 1,95 pund per aktie, vilket innebär en affär på 9 769,5 pund eller cirka 132 000 kronor. Det framgår av Finansinspektionens insynsregister. Enligt bolagets hemsida ägde han inga aktier tidigare. /Finwire Smallcap.

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #12

      Ang. Genovis Insider Ownership: Der er 6 i alt som har købt eller lagt til inden for de sidste 6 måneder.

      1 Reply Last reply
      0
      • B Offline
        B Offline
        Bjæssing09
        wrote on sidst redigeret af
        #13

        Nyt fra Saniona igen: https://www.placera.se/placera/pressmeddelanden/2024/10/07/saniona-saniona-startar-san711-biomarkorsstudie.html?fbclid=IwZXh0bgNhZW0CMTEAAR0y9xR_zdCD3bcqrg5QQHOiuJpGC8YYWhEOkhuHuxEvqwwqV724Y3F6NV4_aem_M8NiCDd6VaQYGUXsNCqMcQ

        1 Reply Last reply
        0
        • F Offline
          F Offline
          Fandel
          wrote on sidst redigeret af
          #14

          Godmorgen...

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #15

            Gilead Sciences : Phase 3 Data Shows 96% Reduction In HIV Infections With Lenacapavir https://proinvestor.com/investornyt/1224040/gilead-sciences-phase-3-data-shows-96-reduction-in-hiv-infections-with-lenacapavir

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #16

              Indivior Announces FDA Grants Priority Review For SUBLOCADE Prior Approval Supplement https://proinvestor.com/investornyt/1224036/indivior-announces-fda-grants-priority-review-for-sublocade-prior-approval-supplement

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #17

                Vincerx Reports Positive Initial Clinical Data From VIP943 Phase 1 Dose-Escalation Study https://proinvestor.com/investornyt/1224048/vincerx-reports-positive-initial-clinical-data-from-vip943-phase-1-dose-escalation-study

                1 Reply Last reply
                0
                • exitnuE Offline
                  exitnuE Offline
                  exitnu
                  wrote on sidst redigeret af
                  #18

                  Nordea höjer Genovis till köp (behåll), riktkurs 28 kronor

                  1 Reply Last reply
                  0
                  • F Offline
                    F Offline
                    Fandel
                    wrote on sidst redigeret af
                    #19

                    Godmorgen...

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #20

                      FDA Approves Genentech's Itovebi For Advanced Breast Cancer With PIK3CA Mutation https://proinvestor.com/investornyt/1225691/fda-approves-genentechs-itovebi-for-advanced-breast-cancer-with-pik3ca-mutation

                      1 Reply Last reply
                      0
                      • F Offline
                        F Offline
                        Fandel
                        wrote on sidst redigeret af
                        #21

                        Godmorgen...

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #22

                          FDA Approves Pfizer's HYMPAVZI For Hemophilia A And B Treatment In Adults And Adolescents https://proinvestor.com/investornyt/1226235/fda-approves-pfizers-hympavzi-for-hemophilia-a-and-b-treatment-in-adults-and-adolescents

                          1 Reply Last reply
                          0
                          • F Offline
                            F Offline
                            Fandel
                            wrote on sidst redigeret af
                            #23

                            Godmorgen...

                            1 Reply Last reply
                            0
                            • F Offline
                              F Offline
                              Fandel
                              wrote on sidst redigeret af
                              #24

                              Godmorgen...

                              1 Reply Last reply
                              0
                              • L Offline
                                L Offline
                                LP90
                                wrote on sidst redigeret af
                                #25

                                Godmorgen 🙂

                                1 Reply Last reply
                                0
                                • HenrikhotH Offline
                                  HenrikhotH Offline
                                  Henrikhot
                                  wrote on sidst redigeret af
                                  #26

                                  https://saniona.com/newsroom/single-press-release/?slug=saniona-ion-channel-research-collaboration-with-boehringer-ingelheim-reaches-milestone
                                  Saniona Ion Channel Research Collaboration with Boehringer Ingelheim Reaches Milestone
                                  October 14, 2024 at 8:00:00 AM

                                  1 Reply Last reply
                                  0
                                  • F Offline
                                    F Offline
                                    Fandel
                                    wrote on sidst redigeret af
                                    #27

                                    Godmorgen...

                                    1 Reply Last reply
                                    0
                                    • L Offline
                                      L Offline
                                      LP90
                                      wrote on sidst redigeret af
                                      #28

                                      Godmorgen 🙂

                                      1 Reply Last reply
                                      0
                                      • F Offline
                                        F Offline
                                        Fandel
                                        wrote on sidst redigeret af
                                        #29

                                        Godmorgen...

                                        1 Reply Last reply
                                        0
                                        • L Offline
                                          L Offline
                                          LP90
                                          wrote on sidst redigeret af
                                          #30

                                          Godmorgen 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper